A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males
Clinical trial NCT00434785 · COMPLETED
Trial details
- NCT number
- NCT00434785
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.